Lorbrena 100 mg (Lorlatinib TABLET) 100 MG

Lorbrena 100 mg tablets contain lorlatinib, a medication used to treat certain types of cancer. This oral tablet is manufactured by Pfizer Canada ULC and is designed for specific therapeutic uses.

Strength

100 MG

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lorbrena 100 mg tablets are primarily used in the treatment of advanced non-small cell lung cancer. Lorlatinib, the active ingredient, is a targeted therapy that works by inhibiting specific proteins involved in cancer cell growth. This medication is often prescribed for patients who have certain genetic markers or have not responded to other treatments.

Side Effects

Common effects of Lorbrena 100 mg tablets may include fatigue, nausea, and dizziness. Some individuals might experience changes in mood or appetite. It's important to discuss any persistent or severe effects with a healthcare provider.

Precautions & Warnings

Lorbrena 100 mg tablets should be handled with care and stored as directed. This medication may interact with other drugs, so it's crucial to inform your healthcare provider about all medications you are taking. Pregnant women or those planning to become pregnant should consult a healthcare provider before using this medication.

Avoid Interactions

Lorbrena 100 mg tablets may interact with certain medications, including those that are metabolized by the liver. Alcohol and other substances that affect liver function should be avoided. Always consult a healthcare provider before combining Lorbrena with other medications.

Frequently Asked Questions

Lorbrena 100 mg tablets are used to treat advanced non-small cell lung cancer, particularly in patients with specific genetic markers.

Lorbrena 100 mg tablets are taken orally, typically once daily. Follow the instructions provided by your healthcare provider.

Common side effects may include fatigue, nausea, dizziness, and changes in mood or appetite.

Lorbrena may interact with other medications, so it's important to consult a healthcare provider before combining it with other drugs.

Pregnant women or those planning to become pregnant should consult a healthcare provider before using Lorbrena.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.